ATS 2018 International Conference - Mobile

Marie-Pierre Malice

MSc

AstraZeneca

Session(s)

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Trial of AZD8871, a Novel Dual-Act...
Monday, May 21 9:15 AM - 9:30 AM